Logo
Saturday, August 23, 2025

The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Health Equity

Stay updated with the latest insights and developments in cancer care.

AEGEAN trial: A phase 3 study of Neoadjuvant Durvalumab plus Chemotherapy followed by Adjuvant Durvalumab versus Neoadjuvant Chemotherapy in Patients with Resectable Non-Small Cell Lung Cancer
Health Equity

AEGEAN trial: A phase 3 study of Neoadjuvant Durvalumab plus Chemotherapy followed by Adjuvant Durvalumab versus Neoadjuvant Chemotherapy in Patients with Resectable Non-Small Cell Lung Cancer

By Editorial Team

By Dr. Dipesh Uprety [Karmanos Cancer Institute](https://www.karmanos.org/karmanos/karmanos-home)   Four cycles of cisplatin-based adjuvant chemotherapy after surgical resection have remained the stan...

2022 Updates in Lung Cancer Treatment
Health Equity

2022 Updates in Lung Cancer Treatment

By Binay Shah, MD

By Dr. Kanak Parmar [Texas Tech University](https://www.ttu.edu/)   ### **Perioperative systemic therapy for resectable non-small cell lung cancer** Surgical resection followed by adjuvant chemothe...

AGILE trial—Ivosidenib plus Azacitidine versus Azacitidine in IDH1 Mutated Acute Myeloid Leukemia
Health Equity

AGILE trial—Ivosidenib plus Azacitidine versus Azacitidine in IDH1 Mutated Acute Myeloid Leukemia

By Binaytara Team

Dr. Aditi Sharma of [Barbara Ann Karmanos Cancer Institute](https://www.karmanos.org/karmanos/karmanos-home) & Dr. Abhishek Mangaonkar of [Mayo Clinic](https://www.mayoclinic.org/)   In the phase III ...

Announcing Binaytara's 2023 Summit on Cancer Health Disparities (SCHD23)
Health Equity

Announcing Binaytara's 2023 Summit on Cancer Health Disparities (SCHD23)

By Editorial Team

The conference will be held at the Grand Hyatt in Seattle on April 28-30, 2023 ------------------------------------------------------------------------------ We invite you to attend the 2023 Summit o...

Binaytara Foundation Announces Dr. Umang Swami as Editor-in-Chief of the International Journal of Cancer Care & Delivery (IJCCD)
Health Equity

Binaytara Foundation Announces Dr. Umang Swami as Editor-in-Chief of the International Journal of Cancer Care & Delivery (IJCCD)

By Editorial Team

Swami Envisions the IJCCD as a Leading Journal in Cancer Health Disparities --------------------------------------------------------------------------- The Binaytara Foundation has named Dr. Umang Sw...

A recap from our 2nd Annual Charity Gala Dinner
Health Equity

A recap from our 2nd Annual Charity Gala Dinner

By Editorial Team

Binaytara’s Second Annual Gala Dinner was held on July 24, 2021, at the Crowne-Plaza Downtown Seattle and over 100 guests came out to support the organization’s efforts to eliminate global cancer care...

April brings awareness to testicular cancer
Health Equity

April brings awareness to testicular cancer

By Editorial Team

[Read](https://btfnews.medium.com/april-brings-awareness-to-testicular-cancer-f58c7407ae0e) this article at our old newsletter website...

Page 4 of 4
(37 articles)